D

Denali Therapeutics

Biotechnology Research · United States · 1,000 employees

117 Decision makers
+14 New (6 months)
1,000 Employees
$4M Revenue
2015 Founded

Organizational Chart of Denali Therapeutics

Roles identified within Denali Therapeutics's leadership team, from public professional data, updated 25 Oct 2026.

Department

Hiring This department is actively hiring right now.

Denali Therapeutics's Full Organizational Chart

Loading…

Get their contacts on Zeliq →

Job title Department People Action

Decision makers at Denali Therapeutics by function

General management

Finance

Human resources

See all Denali Therapeutics contacts on Zeliq

Decision makers at Denali Therapeutics

117 identified 2 C-Level 9 VP 106 Directors +14 new (6 months)
See them on Zeliq →

Departments actively hiring 9 departments

Education
General management
Human resources
Marketing
Medical
Operations
Other
Project management
Research

These departments at Denali Therapeutics are actively recruiting: a strong signal to time your outreach.

Funding and news at Denali Therapeutics

Funding

Last round Other · $200M
Total funding $1.3B (7 rounds)
Venture Round N/A Jan 2009
Series A $217M May 2015
Venture Round N/A Sep 2015
Series B $130M Aug 2016
Post-IPO Equity $275M Oct 2022
Post-IPO Equity $500M Feb 2024
Post-IPO Debt $200M Dec 2025

Latest news at Denali Therapeutics

  1. Appointment

    New Sr. Director, Clinical Operations appointed — Medical

  2. Appointment

    New Senior Director, Patent Agent appointed — Legal

  3. Appointment

    New Executive Director HR Operations appointed — Human resources

  4. Appointment

    New Associate Director, Hris appointed — Human resources

  5. Appointment

    New Director, Clinical Regulatory appointed — Medical

Get these new hires' email and phone →

Team Structure headcount by department

Hiring Research
161
Hiring Other
59
Hiring Medical
50
Hiring Operations
45
Hiring Project Management
41
Technical
38
Hiring General Management
31
Finance
14

How to prospect Denali Therapeutics's departments

Research

With 161 people, this is the organisation's biggest team, and it is hiring. Researchers respond to substance: reference publications, benchmarks or datasets relevant to their field.

Other

A team of 59 people, currently hiring. Hard to read from the outside: use a first exchange to map who does what before pushing an offer.

Medical

This 50-person department is actively recruiting. Medical teams trust peer references: name comparable organisations you already serve.

Operations

Hiring is underway in this team of 45 people. Process efficiency and cost control are the angles that resonate with these decision makers.

Project Management

A team of 41 people, currently hiring. Methodology debates are constant here: anchor your pitch in their existing framework rather than against it.

General Management

This 31-person department is actively recruiting. A good executive approach often starts lower in the organisation: build an internal champion before going top-down.

Try the Zeliq email finder demo →

FAQ Denali Therapeutics

Who runs Denali Therapeutics?

The highest-ranking leadership role identified at Denali Therapeutics is “CEO”, based on public data updated 25 Oct 2026.

How many decision makers does Denali Therapeutics have?

117 decision makers identified, including 2 at executive level.

How do I contact a decision maker at Denali Therapeutics?

Verified emails and phone numbers are available in Zeliq, with free credits at sign-up.

Which departments are hiring at Denali Therapeutics?

Education, General management and Human resources, based on published job offers as of 25 Oct 2026.

Companies similar to Denali Therapeutics

More companies to explore

Biotechnology Research · United States

All Biotechnology Research companies in United States →

About Denali Therapeutics

Denali Therapeutics operates in the Biotechnology Research industry, based in United States. The company was founded in 2015 and employs approximately 1,000 people. Denali Therapeutics belongs to the Professional Services sector, with a specific positioning on Biotechnology Research. Denali Therapeutics is a B2B company, primarily serving business clients and professional organisations. The company has secured 7 rounds of funding totalling $1.3B. The company generates approximately $4M in annual revenue. This profile compiles key information about Denali Therapeutics, including industry, size, location, business signals, and B2B contacts, to help sales teams qualify the account and identify the right decision makers before reaching out.

Activity & Market

Denali Therapeutics is positioned on the Biotechnology Research segment, within the Professional Services sector. As a B2B company, Denali Therapeutics primarily serves business clients and professional organisations. In terms of structure, it is registered as “Public company”.